United Therapeutics (UTHR) director Tracey Kevin files Form 3 showing no stock ownership

Rhea-AI Filing Summary

United Therapeutics Corp director Tracey Kevin filed an initial ownership report on Form 3. The filing states that no United Therapeutics securities are beneficially owned. This means the reporting person, who is a director of the company, is formally disclosing that they do not currently hold any direct or indirect ownership in the company’s stock or derivative securities under the applicable reporting rules.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tracey Kevin

(Last) (First) (Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING MD 20910

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2026

3. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ John S. Hess, Jr. under Power of Attorney	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the United Therapeutics (UTHR) Form 3 filed by Tracey Kevin show?

The Form 3 for United Therapeutics (UTHR) shows that director Tracey Kevin reports no beneficial ownership of the company’s securities, including both stock and derivative securities.

What is Tracey Kevin’s relationship to United Therapeutics (UTHR)?

Tracey Kevin is identified in the filing as a director of United Therapeutics Corp and is not listed as an officer or 10% owner.

Are any United Therapeutics (UTHR) shares or options reported as owned on this Form 3?

No. The filing explicitly states in the remarks that no securities are beneficially owned, and both the non-derivative and derivative tables contain no holdings.

Does this United Therapeutics Form 3 include any insider transactions?

No. The Form 3 is an initial ownership report for director Tracey Kevin and lists no transactions and no securities beneficially owned.

Why is a Form 3 filed when no United Therapeutics securities are owned?

When someone becomes a director of United Therapeutics, they must file a Form 3 to report their initial ownership status, even if they currently have no beneficial ownership in the company’s securities.